- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hybio Pharmaceutical (300199)
Hybio Pharmaceutical stock price live, this page displays SZ 300199 stock exchange data. View the 300199 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hybio Pharmaceutical real time stock price chart below.
What Is the Hybio Pharmaceutical Stock Price Today?
The Hybio Pharmaceutical stock price today is 14.39.
What Is the Stock Symbol for Hybio Pharmaceutical?
The stock symbol for Hybio Pharmaceutical is "300199."
What Stock Exchange Does Hybio Pharmaceutical Trade On?
Hybio Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Hybio Pharmaceutical a Good Stock to Buy?
Determining whether Hybio Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300199 quote. (ISIN: CNE1000011T7)
What Is the Hybio Pharmaceutical Stock Price Today?
The Hybio Pharmaceutical stock price today is 14.39.
What Is the Stock Symbol for Hybio Pharmaceutical?
The stock symbol for Hybio Pharmaceutical is "300199."
What Stock Exchange Does Hybio Pharmaceutical Trade On?
Hybio Pharmaceutical is listed and trades on the Shenzhen stock exchange.
Is Hybio Pharmaceutical a Good Stock to Buy?
Determining whether Hybio Pharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300199 quote. (ISIN: CNE1000011T7)
Shenzhen
Currency in CNY
14.39
+0.30(+2.13%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.95
14.44
52 wk Range
8.83
16.54
300199 Scorecard
Full Analysis
Short term obligations exceed liquid assets
Earnings results expected tomorrow
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.9514.44
52 wk Range
8.8316.54
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300199 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Not profitable over the last twelve months
Hybio Pharmaceutical Company Profile
Hybio Pharmaceutical Co., Ltd. engages in the development, manufacture, and commercialization of therapeutic peptides API and peptide-based drugs in China and internationally. It offers liraglutide, semaglutide, and exenatide for diabetes; terlipressin, desmopressin, and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix, and atosiban for obstetrics and gynecology; customized peptides; working standards for the peptide APIs and related impurities; peptide CRO; and CDMO services, which include peptide API synthesis and purification process development, finish dosage form development, reference standard preparation and qualification, impurity and product quality study and analysis, GMP system meeting EU and FDA standard, international and Chinese regulatory, and dossier support. The company was founded in 1998 and is based in Wuhan, China.
Compare 300199 to Peers and Sector
Metrics to compare | 300199 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300199PeersSector | |
|---|---|---|---|---|
P/E Ratio | −141.7x | −1.0x | −0.5x | |
PEG Ratio | −1.67 | 0.03 | 0.00 | |
Price/Book | 19.6x | 2.8x | 2.6x | |
Price / LTM Sales | 16.9x | 5.3x | 3.0x | |
Upside (Analyst Target) | - | 26.8% | 53.7% | |
Fair Value Upside | Unlock | −3.8% | 8.4% | Unlock |
Earnings
Latest Release
Apr 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the Hybio Pharmaceutical (300199) Stock Price Today?
The Hybio Pharmaceutical stock price today is 14.39.
What Stock Exchange Does Hybio Pharmaceutical Trade On?
Hybio Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Hybio Pharmaceutical?
The stock symbol for Hybio Pharmaceutical is "300199."
What Is the Hybio Pharmaceutical Market Cap?
As of today, Hybio Pharmaceutical market cap is 12.71B.
What Is Hybio Pharmaceutical's Earnings Per Share (TTM)?
The Hybio Pharmaceutical EPS (TTM) is -0.10.
When Is the Next Hybio Pharmaceutical Earnings Date?
Hybio Pharmaceutical will release its next earnings report on 18 May 2025.
From a Technical Analysis Perspective, Is 300199 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.